Navigation Links
AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
Date:12/8/2008

cognitively impaired.

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.35 billion dollar healthcare business with 12,200 employees committed to improving people's lives. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. For more information visit www.astrazeneca-us.com.

About Targacept

Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics (TM), a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept's product candidates selectively modulate neuronal nicotinic receptors that serve as key regulators of the nervous system to promote therapeutic effects and limit adverse side effects. Targacept has product candidates in development for Alzheimer's disease, cognitive dysfunction in schizophrenia, pain and depression, as well as multiple preclinical programs. Targacept also has a cognition-focused collaboration with AstraZeneca and a strategic alliance with GlaxoSmithKline. Targacept's news releases are available on its website at www.targacept.com.

(1) IntegNeuro is a computerized test battery that assesses multiple domains of cognitive function. Five of the domains, Attention/Vigilance, Working Memory, Verbal Learning, Speed of Processing and Reasoning and Problem Solving, were considered primary
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA
2. AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimers Disease
3. AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
4. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
5. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
6. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
7. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
8. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
9. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
10. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
11. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Nov. 6 California American Water...o Drugs Down the Drain" week for its San Diego Cou...onsored by public and private agencies alike towar...llution in our source water supplies. ,, Califo...re encouraged to drop off expired or unwanted phar...
(Date:11/5/2009)..., N.J., Nov. 5 Osteotech...field of biologic products for regenerative healin...quarter ended September 30, 2009. ,, "During th...ase of our three new biologic products MagniFuse(...d Plexur M® Innovative Grafting," said Sam Ow...
(Date:11/5/2009)...HMOND, Calif., Nov. 5 Tr...specialty pharmaceutical company focused on the de...ducts that address important therapeutic needs in ... host a webcast and teleconference with management...n Thursday, November 12, 2009, at 5:00 p.m. Easter...
Breaking Medicine Technology:California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2New Test Assesses Individual Breast Cancer Risk 58896 1New Test Assesses Individual Breast Cancer Risk 58896 2New Test Assesses Individual Breast Cancer Risk 58896 3Antidepressants May Be Linked to Birth Problems 58893 1Antidepressants May Be Linked to Birth Problems 58893 2VBI awarded 2427 million from NIH to support infectious disease research 10266 1VBI awarded 2427 million from NIH to support infectious disease research 10266 2VBI awarded 2427 million from NIH to support infectious disease research 10266 3VBI awarded 2427 million from NIH to support infectious disease research 10266 4
...ORK, June 13, 2007--Three new drugs for,rheumatoid...ment,for this difficult and debilitating condition...udy published early Online and in an,upcoming edit...chronic,inflammatory joint diseases, affecting 0&m...alised world. Its typical symptoms are,joint pain,...
... TIKVA, Israel--(BUSINESS WIRE)--Jun 14, 2007 - Ca...any traded on the Tel,Aviv Stock Exchange Exchange...CF502; this is in addition to CF101, which is curr...eclinical phases. This,weekend Can-Fite will prese...-vitro and in vivo study results showing effective...
Other Medicine Technology:Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment 2Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment 3Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2
(Date:11/8/2009)...HINGTON, Nov. 7 USActio...alth Care for America Act, which will make health ... companies accountable and increase access to heal... option. ,, "Teddy Roosevelt, FDR and Harry Tru...r Alan Charney. "Today,s vote ranks among our coun...
(Date:11/8/2009)...lls for Swift Passage of H.R. 3961 to Secure the S...swire-USNewswire/ -- Statement Attributable to: J....ssociation. ,, (Logo: http://www.newscom.com/...ails the passage of the House health reform bill, ...ents and physicians and calls for swift passage of...
(Date:11/8/2009)...RP Praises House Passage of Health Care Reform Bil...dicare, improve coverage for all Americans ,, ...the United States House of Representatives passed ...legislation that would strengthen Medicare for sen... that prices millions of Americans out of affordab...
(Date:11/8/2009)...RP Praises House Passage of Health Care Reform Bil...dicare, improve coverage for all Americans ,, ...ARY: Tonight the United States House of Represent...ion that would strengthen Medicare for seniors and...ices millions of Americans out of affordable healt...
(Date:11/7/2009)...HINGTON, Nov. 7 Karen I...rance Plans (AHIP), released the following stateme...lth plans strongly support comprehensive health ca...ion by proposing a complete overhaul of how health...osed guaranteed coverage, elimination of pre-exist...
Breaking Medicine News(10 mins):Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2
...Explores Psychological, Social, Physical and Educa...IL (PRWEB) January 5, 2009 -- Since the advent of ...onger game play, two things have occurred in the v...nies, over what effect videos games have on childr...
...anuary 13, 2009 , 10:00 a.m. Eastern Standard Time... , Locations of Initial Recruitment , , WASHING...ional Institutes of Health: , , What: A media t...nited States, the National Children,s study will f...
...ection Saves Pets , Kansa...u commit to your new year,s resolutions or not, ve... Center of Kansas City are urging you to commit t... lead to a loved one,s life saved and less costly ...
...rging technologies can create environments that re...e University researcher thinks games like Nintendo...edentary activities for people of all ages. , "I ...department of kinesiology at K-State and director ...
...mming from the catastrophic,October 15, 2008 crash...nois,was filed today on behalf of Robert and Brook...r 14-month-old daughter Kirstin Reann Blockinger. ...al,Hospital hit a radio tower and its supporting s...
...harmaceuticals, Inc. (Nasdaq: ONXX ) today annou...hts to SB1518, an orally available, potent, and se...1578, also a JAK2 inhibitor, from S*BIO Pte Ltd ba...yx as ONX 0803) and SB1578 (designated by Onyx as ...
Other Medicine News:Health News:Psychiatrist Examines Effects of Video Game Play on Children 2Health News:Psychiatrist Examines Effects of Video Game Play on Children 3Health News:Telebriefing: National Children's Study Recruitment Begins 2Health News:Tips on When to Bring Pets to Animal ER 2Health News:Tips on When to Bring Pets to Animal ER 3Health News:Wii Fit a promising tool for all ages 2Health News:Wii Fit a promising tool for all ages 3Health News:Nolan Law Group Files Lawsuit on Behalf of the Parents of a 14-Month-Old Girl Killed in October 15th 2008 Medical Evacuation Helicopter Crash Near Aurora, Illinois 2Health News:Nolan Law Group Files Lawsuit on Behalf of the Parents of a 14-Month-Old Girl Killed in October 15th 2008 Medical Evacuation Helicopter Crash Near Aurora, Illinois 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 2Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 3Health News:Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO 4
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: